EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Peripheral intravenous therapy infiltration/extravasation (PIVIE) risks and the potential for earlier notification of events using a novel sensor technology in a neonatal population

Matheus Fpt van Rens iD, Daniel Vijlbrief, Sophie Braun, Kevin Hugill, Fredericus Hj van Loon iD, Agnes van de Hoogen

The Journal of Vascular Access · 2024

DOI: 10.1177/11297298231185536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Vascular Access, 2024. Verfasst von Matheus Fpt van Rens und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neonatal Intensive Care Unit, Women's Wellness and Research Center, Doha, Qatar. Hauptthemen laut MEDLINE: Catheterization, Peripheral, Intensive Care Units, Neonatal, Feasibility Studies, Extravasation of Diagnostic and Therapeutic Materials. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intravenous (IV) therapy using short peripheral IV catheters (PIVC) is commonplace with neonatal patients. However, this therapy is associated with high complication rates including the leakage of infused fluids from the vasculature into the surrounding tissues; a condition referred to as, peripheral IV infiltration/extravasation (PIVIE).

Objective

The quality improvement project aimed to identify the prevalence of known risk factors for PIVIE in the neonatal intensive care unit (NICU) and explore the feasibility of using novel optical sensor technology to aid in earlier detection of PIVIE events.

Methods

The plan, do, study, act (PDSA) model of quality improvement (QI) was used to provide a systematic framework to identify PIVIE risks and evaluate the potential utility of continuous PIVC monitoring using the ivWatch model 400 ® system. The site was provided with eight monitoring systems and consumables. Hospital staff were supported with theoretical education and bedside training about the system operations and best use practices.

Results

In total 113 PIVIE’s (graded II–IV) were recorded from 3476 PIVCs, representing an incidence of 3.25%. Lower birth weight and gestational age were statistically significant factors for increased risk of PIVIE ( p = 0.004); all other known risk factors did not reach statistical significance. Piloting the ivWatch with 21 PIVCs using high-risk vesicant solutions over a total of 523.9 h (21.83 days) detected 11 PIVIEs (graded I–II). System sensitivity reached 100%; 11 out of 11 PIVIEs were detected by the ivWatch before clinician confirmation.

Conclusions

Prevailing risk factors for PIVIE in the unit were comparable to those published. Continuous infusion site monitoring using the ivWatch suggests this technology offers the potential to detect PIVIE events earlier than relying on intermittent observation alone (i.e. the current standard of care). However, large-scale study with neonatal populations is required to ensure the technology is optimally configured to meet their needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Catheterization, PeripheralIntensive Care Units, NeonatalFeasibility StudiesExtravasation of Diagnostic and Therapeutic MaterialsQuality ImprovementHumansInfant, NewbornRisk FactorsInfusions, IntravenousRisk AssessmentFemaleTime FactorsGestational AgeMalePredictive Value of TestsIntensive Care, NeonatalBirth WeightEquipment Design

Stichwörter der Autor:innen

Neonateperipheral intravenous infiltration/extravasation (PIVIE)quality improvementsensor-technologyvascular access

Autor:innen und Institutionen

  • Neonatal Intensive Care Unit, Women's Wellness and Research Center, Doha, Qatar.
  • Department of Neonatology, Wilhelmina Children's Hospital, UMC Utrecht, Utrecht, The Netherlands.
  • Hamad Medical Corporation, Doha, Qatar.
  • Department of Perioperative Care and Technology, Fontys University of Applied Sciences, Eindhoven, The Netherlands.
  • Department of Anesthesiology, Intensive Care and Pain Medicine, Catharina Hospital, Eindhoven, The Netherlands.
  • Clinical Health Science at Utrecht University (UU), Utrecht, The Netherlands.

ORCID-Profile: Matheus Fpt van Rens, Fredericus Hj van Loon

Zitieren

APA

van Rens, M. F., Vijlbrief, D., Braun, S., Hugill, K., van Loon, F. H., & van de Hoogen, A. (2024). Peripheral intravenous therapy infiltration/extravasation (PIVIE) risks and the potential for earlier notification of events using a novel sensor technology in a neonatal population. The Journal of Vascular Access. https://doi.org/10.1177/11297298231185536

Vancouver

van Rens MF, Vijlbrief D, Braun S, Hugill K, van Loon FH, van de Hoogen A. Peripheral intravenous therapy infiltration/extravasation (PIVIE) risks and the potential for earlier notification of events using a novel sensor technology in a neonatal population. The Journal of Vascular Access. 2024. doi:10.1177/11297298231185536

BibTeX
@article{vanRens2024,
  author = {van Rens, Matheus Fpt and Vijlbrief, Daniel and Braun, Sophie and Hugill, Kevin and van Loon, Fredericus Hj and van de Hoogen, Agnes},
  title = {Peripheral intravenous therapy infiltration/extravasation (PIVIE) risks and the potential for earlier notification of events using a novel sensor technology in a neonatal population},
  journal = {The Journal of Vascular Access},
  year = {2024},
  doi = {10.1177/11297298231185536}
}
Kostenlos starten →